ANTIBIOTIC
THERAPY
AND
CYSTIC
FIBROSIS
INCREASED
RESISTANCE
OF
MUCOID
PSEUDOMONAS
AERUGINOSA
TO
CARBENICILLIN
THE
PRESENT
COMMUNICATION
REPORTS
THE
EFFECT
OF
THE
BACTERIAL
MUCUS
ON
THE
ACTIVITY
OF
ANTIBODIES
ON
STRAINS
OF
P
AERUGINOSA
MUCOID
VARIANTS
OF
P
AERUGINOSA
OBTAINED
FROM
THE
NONMUCOID
STRAINS
PAO
381
AND
PAT
404
BY
SELECTION
FOR
PHENOTYPIC
RESISTANCE
TO
THE
VIRULENT
PHAGE
E
79
WERE
MORE
RESISTANT
TO
CARBENICILLIN
THAN
THE
NONMUCOID
PARENT
STRAINS
MUCOID
P
AERUGINOSA
STRAINS
ISOLATED
FROM
TWO
CF
PATIENTS
WERE
MORE
RESISTANT
TO
CARBENICILLIN
THAN
NONMUCOID
STRAINS
ISOLATED
FROM
THE
SAME
SAMPLES
OF
SPUTUM
WHEN
THE
EXPERIMENTS
ALREADY
DESCRIBED
WERE
REPEATED
WITH
OXYTETRACYCLINE
IN
CONTRAST
TO
OUR
EXPERIENCE
WITH
CARBENICILLIN
MUCOID
STRAINS
WERE
FOUND
TO
BE
MORE
SENSITIVE
THAN
NONMUCOID
STRAINS
TO
PROVE
THE
HYPOTHESIS
THAT
MUCOID
STRAINS
CAN
BE
SELECTED
IN
VIVO
BY
CARBENICILLIN
THERAPY
IT
WILL
BE
NECESSARY
TO
SHOW
THAT
THE
LEVEL
OF
CARBENICILLIN
IN
CF
SECRETIONS
IS
LESS
THAN
THE
MINIMUM
INHIBITORY
CONCENTRATIONS
OF
MUCOID
STRAINS
BUT
GREATER
THAN
THAT
OF
NONMUCOID
STRAINS
WE
ARE
NOW
INVESTIGATING
ADDITIONAL
CF
ISOLATES
IN
CONJUNCTION
WITH
THE
RANGE
OF
ANTIBIOTICS
USED
IN
CHEMOTHERAPY
OF
CF
PATIENTS
